Foreign-Trade Zone 22-Chicago, IL, Application for Subzone Baxter Healthcare Corporation (Pharmaceutical and Biological Product Manufacturing), Round Lake, IL, 65448 [2010-26925]

Download as PDF 65448 Federal Register / Vol. 75, No. 205 / Monday, October 25, 2010 / Notices Committee discussion is limited to Forest Service staff and Committee members. However, public input opportunity will be provided and individuals will have the opportunity to address the Committee at that time. Dated: October 15, 2010. Jason C. Anderson, District Ranger. [FR Doc. 2010–26892 Filed 10–22–10; 8:45 am] BILLING CODE 3410–11–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [Docket 60–2010] emcdonald on DSK2BSOYB1PROD with NOTICES Foreign-Trade Zone 22–Chicago, IL, Application for Subzone Baxter Healthcare Corporation (Pharmaceutical and Biological Product Manufacturing), Round Lake, IL An application has been submitted to the Foreign-Trade Zones Board (the Board) by the Illinois International Port District, grantee of FTZ 22, requesting special-purpose subzone status for the pharmaceutical and biological intravenous (I.V.) product manufacturing facility of Baxter Healthcare Corporation (Baxter), located near Round Lake (Lake County), Illinois. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a– 81u), and the regulations of the Board (15 CFR part 400). It was formally filed on October 15, 2010. The Baxter facility (500 manufacturing employees, approximately 154 acres/1,427,047 square feet (303,831 manufacturing square feet)) is located at 25212 W. Illinois Route 120, near Round Lake, Illinois. Activity to be conducted under FTZ procedures would include manufacturing, warehousing and distribution of pre-mixed, filled pharmaceutical and biological I.V. units (up to 70 million units annually) for export and the domestic market. Baxter is requesting to use zone procedures for the foreign-origin laminated film used to make the I.V. bags (HTSUS 3920.10, duty rate: 4.2%), representing some 7.5 percent of the finished product’s value. FTZ procedures could exempt Baxter from customs duty payments on the foreign laminated film used in export production (up to some 7 percent of annual shipments). On its domestic sales, Baxter would be able to choose the duty rate during customs entry procedures that applies to the finished pharmaceutical and biological I.V. VerDate Mar<15>2010 16:05 Oct 22, 2010 Jkt 223001 products (duty-free) for the foreign input noted above. FTZ designation may further allow Baxter to realize logistical benefits through the use of weekly customs entry and direct delivery procedures. The request indicates that the savings from FTZ procedures would help improve the plant’s international competitiveness. In accordance with the Board’s regulations, Diane Finver of the FTZ Staff is designated examiner to evaluate and analyze the facts and information presented in the application and case record and to report findings and recommendations to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is December 27, 2010. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to January 10, 2011. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via http:// www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: October 15, 2010. Andrew McGilvray, Executive Secretary. [FR Doc. 2010–26925 Filed 10–22–10; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration [A–570–001] Potassium Permanganate From the People’s Republic of China: Continuation of Antidumping Duty Order Import Administration, International Trade Administration, Department of Commerce. DATES: Effective Date: October 25, 2010. SUMMARY: As a result of the determinations by the Department of Commerce (‘‘Department’’) and the International Trade Commission (‘‘ITC’’) that revocation of the antidumping duty order on potassium permanganate from the People’s Republic of China (‘‘PRC’’) AGENCY: PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 would likely lead to a continuation or recurrence of dumping and material injury to an industry in the United States, the Department is publishing a notice of continuation of the antidumping duty order. FOR FURTHER INFORMATION CONTACT: Alexis Polovina, AD/CVD Operations, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230; telephone: (202) 482–3927. SUPPLEMENTARY INFORMATION: On May 3, 2010, the Department published the notice of initiation of the sunset review of the antidumping duty order on potassium permanganate from the PRC pursuant to section 751(c) of the Tariff Act of 1930, as amended (‘‘the Act’’). See Initiation of Five-Year (‘‘Sunset’’) Review, 75 FR 23240 (May 3, 2010). As a result of its review, the Department determined that revocation of the antidumping duty order on potassium permanganate from the PRC would likely lead to a continuation or recurrence of dumping and, therefore, notified the ITC of the magnitude of the margins likely to prevail should the order be revoked. See Potassium Permanganate from the People’s Republic of China: Final Results of Expedited Sunset Review of Antidumping Duty Order, 75 FR 52509 (August 26, 2010). On September 20, 2010, the ITC determined, pursuant to section 751(c) of the Act, that revocation of the antidumping duty order on potassium permanganate from the PRC would likely lead to a continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable future. See Potassium Permanganate From China Determination, 75 FR 63856 (October 18, 2010), and USITC Publication 4183 (September 2010), Potassium Permanganate from China: Investigation No. 731–TA–125 (Third Review). Scope of the Order Imports covered by the order are shipments of potassium permanganate, an inorganic chemical produced in freeflowing, technical, and pharmaceutical grades. Potassium permanganate is currently classifiable under item 2841.61.00 of the Harmonized Tariff Schedule of the United States (‘‘HTSUS’’). The HTSUS item numbers are provided for convenience and customs purposes. The written description remains dispositive. Continuation of the Order As a result of these determinations by the Department and the ITC that E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 75, Number 205 (Monday, October 25, 2010)]
[Notices]
[Page 65448]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26925]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 60-2010]


Foreign-Trade Zone 22-Chicago, IL, Application for Subzone Baxter 
Healthcare Corporation (Pharmaceutical and Biological Product 
Manufacturing), Round Lake, IL

    An application has been submitted to the Foreign-Trade Zones Board 
(the Board) by the Illinois International Port District, grantee of FTZ 
22, requesting special-purpose subzone status for the pharmaceutical 
and biological intravenous (I.V.) product manufacturing facility of 
Baxter Healthcare Corporation (Baxter), located near Round Lake (Lake 
County), Illinois. The application was submitted pursuant to the 
provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-
81u), and the regulations of the Board (15 CFR part 400). It was 
formally filed on October 15, 2010.
    The Baxter facility (500 manufacturing employees, approximately 154 
acres/1,427,047 square feet (303,831 manufacturing square feet)) is 
located at 25212 W. Illinois Route 120, near Round Lake, Illinois. 
Activity to be conducted under FTZ procedures would include 
manufacturing, warehousing and distribution of pre-mixed, filled 
pharmaceutical and biological I.V. units (up to 70 million units 
annually) for export and the domestic market. Baxter is requesting to 
use zone procedures for the foreign-origin laminated film used to make 
the I.V. bags (HTSUS 3920.10, duty rate: 4.2%), representing some 7.5 
percent of the finished product's value.
    FTZ procedures could exempt Baxter from customs duty payments on 
the foreign laminated film used in export production (up to some 7 
percent of annual shipments). On its domestic sales, Baxter would be 
able to choose the duty rate during customs entry procedures that 
applies to the finished pharmaceutical and biological I.V. products 
(duty-free) for the foreign input noted above. FTZ designation may 
further allow Baxter to realize logistical benefits through the use of 
weekly customs entry and direct delivery procedures. The request 
indicates that the savings from FTZ procedures would help improve the 
plant's international competitiveness.
    In accordance with the Board's regulations, Diane Finver of the FTZ 
Staff is designated examiner to evaluate and analyze the facts and 
information presented in the application and case record and to report 
findings and recommendations to the Board.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the address below. The closing period for their receipt is 
December 27, 2010. Rebuttal comments in response to material submitted 
during the foregoing period may be submitted during the subsequent 15-
day period to January 10, 2011.
    A copy of the application will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via http://www.trade.gov/ftz.
    For further information, contact Diane Finver at 
Diane.Finver@trade.gov or (202) 482-1367.

    Dated: October 15, 2010.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2010-26925 Filed 10-22-10; 8:45 am]
BILLING CODE 3510-DS-P